Towards better dose individualisation: metabolic phenotyping to predict cabazitaxel pharmacokinetics in men with prostate cancer

A Janssen, CPM Verkleij, A van der Vlist, Ron Mathijssen, HJ Bloemendal, R ter Heine

Research output: Contribution to journalArticleAcademicpeer-review

6 Citations (Scopus)
10 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)1312-1317
Number of pages6
JournalBritish Journal of Cancer
Volume116
Issue number10
DOIs
Publication statusPublished - 2017

Research programs

  • EMC MM-03-86-08

Cite this